| Primary |
| Product Used For Unknown Indication |
26.7% |
| Acute Myeloid Leukaemia |
25.2% |
| Acute Lymphocytic Leukaemia |
9.9% |
| Prophylaxis |
9.2% |
| Acute Leukaemia |
6.9% |
| Drug Use For Unknown Indication |
3.7% |
| Bone Marrow Conditioning Regimen |
3.2% |
| Antifungal Prophylaxis |
2.1% |
| Infection |
2.0% |
| Pyrexia |
1.9% |
| Haematological Malignancy |
1.4% |
| Prophylaxis Against Graft Versus Host Disease |
1.2% |
| Pain |
1.1% |
| Hypertension |
0.9% |
| Acute Lymphocytic Leukaemia Recurrent |
0.9% |
| Acute Myeloid Leukaemia Recurrent |
0.8% |
| Antibiotic Therapy |
0.8% |
| Nausea |
0.7% |
| Antibiotic Prophylaxis |
0.7% |
| Antiviral Prophylaxis |
0.7% |
|
| Sepsis |
12.5% |
| Thrombocytopenia |
11.2% |
| Respiratory Failure |
7.8% |
| Pyrexia |
7.6% |
| Multi-organ Failure |
6.8% |
| Septic Shock |
6.5% |
| Pancytopenia |
6.3% |
| Death |
4.2% |
| Renal Failure |
4.2% |
| Neutropenia |
3.9% |
| Infection |
3.7% |
| Acute Myeloid Leukaemia |
3.4% |
| Pneumonia |
3.1% |
| Cerebral Haemorrhage |
2.9% |
| Febrile Neutropenia |
2.9% |
| Tumour Lysis Syndrome |
2.9% |
| Cardiac Failure |
2.6% |
| Neutropenic Sepsis |
2.6% |
| Vomiting |
2.6% |
| Neutropenic Colitis |
2.3% |
|
| Secondary |
| Acute Myeloid Leukaemia |
27.2% |
| Product Used For Unknown Indication |
24.1% |
| Bone Marrow Conditioning Regimen |
9.9% |
| Acute Lymphocytic Leukaemia |
8.1% |
| Prophylaxis |
6.6% |
| Drug Use For Unknown Indication |
3.4% |
| Haematological Malignancy |
2.6% |
| Antifungal Prophylaxis |
2.1% |
| Prophylaxis Against Graft Versus Host Disease |
2.0% |
| Acute Leukaemia |
1.8% |
| B-cell Lymphoma |
1.8% |
| Immunosuppressant Drug Therapy |
1.6% |
| Acute Myeloid Leukaemia Recurrent |
1.3% |
| Myelodysplastic Syndrome |
1.3% |
| Non-hodgkin's Lymphoma |
1.2% |
| Antibiotic Prophylaxis |
1.1% |
| Prophylaxis Of Nausea And Vomiting |
1.1% |
| Hypertension |
1.0% |
| T-cell Lymphoma |
1.0% |
| Acute Lymphocytic Leukaemia Recurrent |
0.9% |
|
| Septic Shock |
12.8% |
| Thrombocytopenia |
9.9% |
| Sepsis |
8.5% |
| Acute Myeloid Leukaemia Recurrent |
7.8% |
| Pancytopenia |
7.1% |
| Pyrexia |
7.1% |
| Respiratory Failure |
6.4% |
| Neutropenia |
5.0% |
| Adenovirus Infection |
4.3% |
| Renal Failure |
3.5% |
| Vomiting |
3.5% |
| Axonal Neuropathy |
2.8% |
| Epilepsy |
2.8% |
| Fasciitis |
2.8% |
| Multi-organ Failure |
2.8% |
| Shock |
2.8% |
| Sinus Tachycardia |
2.8% |
| Transaminases Increased |
2.8% |
| Acute Myeloid Leukaemia |
2.1% |
| Bacteraemia |
2.1% |
|
| Concomitant |
| Acute Myeloid Leukaemia |
100.0% |
|
|
| Interacting |
| Acute Myeloid Leukaemia |
40.0% |
| Product Used For Unknown Indication |
40.0% |
| Drug Use For Unknown Indication |
20.0% |
|
|
